Document:

nxgn-ex101_9.htm

 

Exhibit 10.1

EXECUTION COPY

AMENDMENT NO. 2

Dated as of October 27, 2022

to

CREDIT AGREEMENT

Dated as of March 12, 2021

THIS AMENDMENT NO. 2 (this “Amendment”) is made as of October 27, 2022 by and among NextGen Healthcare, Inc. (the “Borrower”), the financial institutions listed on the signature pages hereof and JPMorgan Chase Bank, N.A., as Administrative Agent (the “Administrative Agent’), under that certain Second Amended and Restated Credit Agreement dated as of March 12, 2021 by and among the Borrower, the Lenders from time to time party thereto and the Administrative Agent (as amended prior to the date hereof, the “Existing Credit Agreement”; and the Existing Credit Agreement as amended by this Amendment, the “Amended Credit Agreement”).  Capitalized terms used herein and not otherwise defined herein shall have the respective meanings given to them in the Amended Credit Agreement (as defined below).

WHEREAS, the Borrower has requested that the requisite Lenders and the Administrative Agent agree to make certain amendments to the Existing Credit Agreement; and

WHEREAS, the Borrower, the Lenders party hereto and the Administrative Agent have so agreed on the terms and conditions set forth herein;

NOW, THEREFORE, in consideration of the premises set forth above, the terms and conditions contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Borrower, the Lenders party hereto and the Administrative Agent hereby agree to enter into this Amendment.

1.Amendments to the Existing Credit Agreement.  Effective as of the Amendment No. 2 Effective Date (as defined below), Section 1.04(b) of the Existing Credit Agreement is amended to amend and restate the proviso appearing at the end of the first sentence thereof as follows: “; provided that, solely for purposes of determining compliance with the Restricted Payment Requirements in connection with any repurchase by the Borrower of its common Equity Interests, this clause (ii) shall not apply to the proceeds of the first issuance of Convertible Debt Securities occurring after the Amendment No. 1 Effective Date.”

2.Conditions of Effectiveness.  The effectiveness of this Amendment (the “Amendment No. 2 Effective Date”) is subject to the satisfaction of the following conditions precedent:

(a)The Administrative Agent shall have received counterparts of this Amendment duly executed by the Borrower and the Required Lenders.

(b)The Administrative Agent shall have received payment of the Administrative Agent’s fees and reasonable and documented out-of-pocket expenses (including reasonable and documented out-of-pocket 

750526378.3

 

fees and expenses of counsel for the Administrative Agent) in connection with this Amendment for which invoices have been presented on or before the Amendment No. 2 Effective Date to the extent such fees and expenses are invoiced at least three (3) Business Days in advance of the Amendment No. 2 Effective Date, or if invoiced thereafter, within thirty (30) days of written demand (including documentation reasonably supporting such request).

3.Representations and Warranties of the Borrower.  The Borrower hereby represents and warrants as follows:

(a)This Amendment and the Amended Credit Agreement constitute legal, valid and binding obligations of the Borrower and, in the case of the Amended Credit Agreement, the other Loan Parties party thereto, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.

(b)As of the date hereof and after giving effect to the terms of this Amendment, (i) no Default or Event of Default has occurred and is continuing or would result therefrom and (ii) the representations and warranties of the Loan Parties set forth in the Amended Credit Agreement and the other Loan Documents are true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or Material Adverse Effect) with the same effect as though made on and as of the date hereof (it being understood and agreed that any representation or warranty which by its terms is made as of a specified date is true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or Material Adverse Effect) only as of such specified date).

4.Reference to and Effect on the Existing Credit Agreement.

(a)Upon the effectiveness hereof, each reference to the Existing Credit Agreement in the Existing Credit Agreement or any other Loan Document shall mean and be a reference to the Amended Credit Agreement.

(b)On behalf of itself and each of the other Loan Parties, the Borrower hereby (i) agrees that, except as otherwise set forth herein, this Amendment and the transactions contemplated hereby shall not limit or diminish the obligations of the Loan Parties arising under or pursuant to the Loan Documents to which each such Loan Party is a party, (ii) reaffirms all of the Loan Parties’ obligations under the Existing Credit Agreement and the other Loan Documents to which each such Loan Party is a party except as specifically modified herein and (iii) acknowledges and agrees that the Existing Credit Agreement and each other Loan Document executed by each such Loan Party remains in full force and effect and is hereby reaffirmed, ratified and confirmed, in each case, except as specifically modified herein.

(c)Except as set forth herein, the execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Lenders or the Administrative Agent under the Existing Credit Agreement or any of the other Loan Documents, nor constitute a waiver of any provision of any of the Loan Documents or any other documents, instruments and agreements executed and/or delivered in connection therewith.

(d)This Amendment is a Loan Document. 

5.Governing Law.  This Amendment shall be governed by and construed in accordance with and governed by the law of the State of New York.  The parties hereto agree that provisions of Sections 9.09 and 9.10 of the Amended Credit Agreement are hereby incorporated by reference, mutatis mutandis.

 

2

 

 

6.Headings.  Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.

7.Counterparts.  This Amendment may be executed by one or more of the parties hereto on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument.  Delivery of an executed counterpart of a signature page of this Amendment that is an Electronic Signature transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page shall be effective as delivery of a manually executed counterpart of this Amendment.  The words “execution,” “signed,” “signature,” “delivery,” and words of like import in or relating to this Amendment shall be deemed to include Electronic Signatures, deliveries or the keeping of records in any electronic form (including deliveries by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page), each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be; provided, that, without limiting the foregoing, (i) to the extent the Administrative Agent has agreed to accept any Electronic Signature, the Administrative Agent and each of the Lenders shall be entitled to rely on such Electronic Signature purportedly given by or on behalf of the Borrower without further verification thereof and without any obligation to review the appearance or form of any such Electronic Signature, and (ii) upon the request of the Administrative Agent or any Lender, any Electronic Signature shall be promptly followed by a manually executed counterpart.

[Signature Pages Follow]

 

 

3

 

 

 

 

IN WITNESS WHEREOF, this Amendment has been duly executed as of the day and year first above written.

 

NEXTGEN HEALTHCARE, INC.,

as the Borrower

 

 

By:/s/ Jamie Arnold 
Name: Jamie Arnold

Title: Chief Financial Officer

 

 

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

JPMORGAN CHASE BANK, N.A.,

individually as a Lender and as Administrative Agent

 

 

By:/s/ Melanie Her 
Name: Melanie Her

Title: Authorized Officer

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

U.S. BANK NATIONAL ASSOCIATION,

as a Lender

 

 

By: /s/ Andrew Williams

Name: Andrew Williams

Title: Senior Vice President

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

BANK OF THE WEST,

as a Lender

 

 

By: /s/ Cecile Segovia

Name: Cecile Segovia

Title: Director

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

CITY NATIONAL BANK,

as a Lender

 

 

By: /s/ Marie-Lou Godinez

Name: Marie-Lou Godinez

Title: Senior Vice President

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

TRUIST BANK,

as a Lender

 

 

By:/s/ Timothy Conway

Name: Timothy Conway

Title: Vice President

 

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

PNC BANK, NATIONAL ASSOCIATION (f/k/a BBVA USA),

as a Lender

 

 

By:/s/ Jonas R. Berglund

Name: Jonas R. Berglund

Title: Senior Vice President

 

 

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

CITIZENS BANK, N.A.,

as a Lender

 

 

By: /s/ Mark Guyeski

Name: Mark Guyeski

Title: Vice President

 

 

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

CIT BANK, A DIVISION OF FIRST-CITIZENS

BANK & TRUST COMPANY as a Lender

 

 

By:/s/ Jean-Pierre Knight

Name: Jean-Pierre Knight

Title: Managing Director

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.

 

 

 

 

 

WELLS FARGO BANK, NATIONAL ASSOCIATION,

as a Lender

 

 

By:/s/ Brandon Moss

Name: Brandon Moss

Title: Vice President

 

 

 

Signature Page to Amendment No. 2 to

Second Amended and Restated Credit Agreement dated as of March 12, 2021

NextGen Healthcare, Inc.a101formseparationagreem

  Exhibit 10.1             JELD-WEN, Inc.                             2645 Silver Crescent Drive, Charlotte, NC 28273 USA                               www.jeld-wen.com                    [DATE]      CONFIDENTIAL    [ADDRESS]    Re: Separation Agreement    Dear [NAME],    Your employment with JELD-WEN, Inc. (“the Company”) will end effect upon your  resignation from the Company on [DATE] (the “Resignation Date”).  Pursuant to the terms of  your employment agreement with the Company dated [DATE] (the “Employment Agreement”),  you also resigned your position as a [TITLE] of [the Company] [and any of the Company’s  subsidiaries] on [DATE]. You are sometimes referred to as “Executive” in this Agreement.     In connection with your departure, the Company is making available to you this departure  and release agreement (this “Agreement”).  Under this Agreement, if you choose to accept it and  do not exercise your right to revoke, as set forth in Paragraph 9, you will receive severance  compensation above and beyond your final paycheck in accordance with Section 5(d) of your  Employment Agreement as set forth below (less applicable withholdings and payment of any  outstanding credit card charges or other debts owed to the Company):  A. Payments  Pay in Lieu of Notice  $ [●]    In lieu of working a 30 days’ notice period, the Company will pay you at your annual  salary rate in effect on the date of resignation for an additional [●] days beyond the Resignation  Date. Payment will be made on the next payroll date following [●] days after your return of an  executed original of this Agreement to [NAME], [TITLE], provided that you have not revoked  this Agreement.      Severance Pay  $ [●]    Representing one year’s base pay and your target annual bonus, severance pay will be  made in [●] equal [bi-weekly/monthly] installments, commencing within [●] days after, either  (1) your return of an executed original of this Agreement to [NAME] or  (2) the resignation date,  whichever is later (the “Severance Period”), provided that you have not revoked this Agreement.    

 

     2  [YEAR] Bonus  $  [●]    You are otherwise eligible to receive a prorated bonus for MIP plan year [●].  Given the  6+6 estimated annual performance falls below threshold performance, the payment will be $[●].       Please note that applicable state and federal tax withholding rules may require the  Company to withhold taxes from these amounts at a higher percentage than typically is required  for payments of regular wages.    B.   Equity    Your stock options, restricted stock units and performance stock units will continue to be  governed by the applicable agreements under which they were granted; [provided, however, that  (i) you shall have [●] years from the Resignation Date to exercise any vested and exercisable  stock options, if you chose to do so; and (ii) that, notwithstanding the foregoing, in consideration  of you making yourself available to the Company for all inquiries and questions during the  Severance Period,] the restricted stock units and performance stock units granted on [DATE]  shall vest in accordance with the terms of such restricted stock units or performance stock units  (based on actual performance), as applicable, on [DATE] as though you were still employed by  the Company. [You will have [●] days from your date of termination to exercise any vested  stock options if you choose to do so. ]In the event you decide to exercise your options, you will  login into the Shareworks website and follow the instructions.    C.   COBRA    You are eligible to participate in the Company’s Health Plan through COBRA. Details  about COBRA elections will be sent separately. [If you elect to continue participation through  COBRA and have completed all necessary paperwork to make a COBRA election,] effective the  first of the month following your termination date, the Company will reimburse you for health  coverage through COBRA for a period of up to [●] months up to the amount the Company  would have paid for insurance on your behalf if you remained employed.      [This payment will be provided to you in form of one lump sum, as soon as practicable  following the Resignation Date, but in no event more than [●] days after the Release becomes  effective and irrevocable in accordance with its terms.]      To obtain reimbursement, send COBRA receipts to:  JELD-WEN, Inc.  Attn: [NAME]  [ADDRESS]    D.   Outplacement Services    You are eligible for outplacement services at a value of up to $[●] to be utilized within  one year of your date of termination. Please coordinate with [NAME] to arrange for such  services.      

 

     3  In exchange for these benefits, which you would otherwise not be entitled to receive, you  agree to the terms described below, which include a general release of claims.       E. Tax Reimbursement/Tax Services     [The Company will reimburse you for your costs associated with [your chosen tax  advisor] assisting in the filing of your U.S. Federal and state and foreign income tax returns for  calendar year [YEAR] to the extent those costs directly relate to your assignment with the  Company (“Assignment Income”) and do not extend to personal tax advice or financial planning.  Your U.S. Federal and state tax returns must be completed by no later than [DATE]. When your  actual U.S. Federal and state tax returns are completed, [your chosen tax advisor] will calculate  your final [theoretical] (U.S.) tax liability related to your Assignment Income. If the hypothetical  tax amount previously withheld by the Company related to your Assignment Income exceeds  this amount, you will be refunded the excess within [●] days after completion of the tax  equalization settlement calculation. If the hypothetical tax amount withheld by the Company  related to your Assignment Income is insufficient to cover this liability, you will be responsible  to pay the difference to the Company within [●] days after completion of the tax equalization  settlement.]     Separation Agreement    1. Release of Claims    Executive hereby irrevocably, fully and finally releases the Company, its parent,  subsidiaries, affiliates, directors, officers, agents and employees (“Releasees”) from all causes of  action, claims, suits, demands or other obligations or liabilities, whether known or unknown,  suspected or unsuspected, that Executive ever had or now has as of the time that Executive signs  this release which relate to his hiring, his employment with the Company, the termination of his  employment with the Company and claims asserted in shareholder derivative actions or  shareholder class actions against the Company and its officers and Board, to the extent those  derivative or class actions relate to the period during which Executive was employed by the  Company.  The claims released include, but are not limited to, any claims arising from or related  to Executive’s employment with the Company, such as claims arising under (as amended) Title  VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in  Employment Act of 1974, the Americans with Disabilities Act, the Equal Pay Act, the Fair Labor  Standards Act, the California Fair Employment and Housing Act, the California Labor Code, the  Employee Retirement Income and Security Act of 1974 (“ERISA”) (except for any vested right  Executive has to benefits under an ERISA plan), the state and federal Worker Adjustment and  Retraining Notification Act, and the California Business and Professions Code; any other local,  state, federal, or foreign law governing employment; and the common law of contract and tort.  In  no event, however, shall any claims, causes of action, suits, demands or other obligations or  liabilities be released pursuant to the foregoing if and to the extent they relate to:   (i) claims for workers’ compensation benefits under any of the Company’s  workers’ compensation insurance policies or funds;   (ii) claims related to Executive’s COBRA rights;  

 

     4   (iii) claims for indemnification from the Company to which Executive is or may  become entitled, including but not limited to claims submitted to an insurance company  providing the Company with directors and officers liability insurance; and   (iv) any claims for benefits under any employee benefit plans of the Company  that become due or owing at any time following Executive’s termination of employment,  including, but not limited to, any ERISA plans, deferred compensation plans or equity  plans.  Executive represents and warrants that he has not filed any claim, charge or complaint  against any of the Releases.  Executive intends that this release of claims cover all claims, whether or not known to  Executive.  Executive further recognizes the risk that, subsequent to the execution of this release,  Executive may incur loss, damage or injury which Executive attributes to the claims encompassed  by this release.  Executive expressly assumes this risk by signing this release and voluntarily and  specifically waives any rights conferred by California Civil Code section 1542 which provides as  follows:  A general release does not extend to claims which the creditor does not know or suspect to  exist in his or her favor which if known by him or her must have materially affected his or  her settlement with the debtor.  Executive also hereby waives any rights under the laws of the Commonwealth of Virginia,  the State of New York, or any other jurisdiction which Executive may otherwise possess that are  comparable to those set forth under California Civil Code section 1542.  Executive represents and warrants that there has been no assignment or other transfer of  any interest in any claim by Executive that is covered by this release.  Executive acknowledges that he has been given at least 21 days in which to review and  consider this release, although Executive is free to execute this release at any time within that 21- day period.  Executive acknowledges that he has been advised to consult with an attorney about  this release.  Executive also acknowledges his understanding that if Executive signs this release,  Executive will have an additional 7 days from the date that Executive signs this release to revoke  that acceptance, which Executive may effect by means of a written notice sent to the General  Counsel of the Company at the Company’s corporate headquarters.  If this 7-day period expires  without a timely revocation, Executive acknowledges and agrees that this release will become final  and effective on the eighth day following the date of Executive’s signature, which eighth day will  be the effective date of this release.  Executive acknowledges and agrees that his execution of this release is supported by  independent and adequate consideration in the form of payments and/or benefits from the  Company to which Executive would not have become entitled if he had not signed this release.  2. Section 409A.    a) It is intended that all of the severance payments payable under this Agreement satisfy, to  the greatest extent possible, the exemptions from the application of Section 409A of the  

 

     5  Code and the regulations and other guidance thereunder and any state law of similar effect  (collectively, "Section 409A") provided under Treasury Regulations Sections 1.409A- 1(b)(4) and 1.409A-1(b)(9), and this Agreement will be construed in a manner that  complies with Section 409A so as not to subject Executive to the payment of the tax,  interest and any tax penalty which may be imposed under Section 409A. The provisions of  this Agreement shall be interpreted in a manner consistent with such intent. To the extent  that any provision of this Agreement would otherwise result in Executive being subject to  payment of any tax, interest or tax penalty under Section 409A, the Company and  Executive agree to amend this Agreement in a manner that brings this Agreement into  compliance with Code Section 409A and preserves to the maximum extent possible the  economic value of the relevant payment or benefit under this Agreement to Executive.  b) With respect to any payments or benefits provided to Executive under this Agreement  which arc subject either in whole or in part to Section 409A, the Company shall discharge  its obligations under this Agreement and the Employment Agreement with respect to such  payments or benefits in compliance with all applicable requirements of Section 409A. If  Executive incurs any taxes or interest as a result of failure by the Company or any agent of  the Company to discharge its obligations under this Agreement in compliance with the  requirements of Section 409A, the Company shall reimburse Executive in full for the  amount of such taxes and interest (and for the amount of any additional taxes payable with  respect to such reimbursement) so that Executive is restored to the same after-tax position  in which Executive would have been in had the noncompliance with Section 409A not  occurred.  c) No severance payments will be made under this Agreement unless Executive's termination  of employment constitutes a "separation from service" (as defined under Treasury  Regulation Section 1.409A-1(h)).  d) For purposes of Section 409A (including, without limitation, for purposes of Treasury  Regulations Section 1.409A-2(b)(2)(iii)), Executive's right to receive any installment  payments under this Agreement (whether severance payments or otherwise) shall be treated  as a right to receive a series of separate payments and, accordingly, each installment  payment hereunder shall at all times be considered a separate and distinct payment.  e) If Executive is a specified employee for purposes of Section 409A(a)(2)(B)(i), any payment  or provision of benefits that is nonqualified deferred compensation subject to Section 409A  and that is made in connection with a separation from service payment event (as determined  for purposes of Section 409A) shall not be paid prior to the earlier of (x) the expiration of  the six-month period measured from the date of Executive's separation from service or (y)  the date of Executive's death (the "409A Deferral Period"). In the event such payments are  otherwise due to be made in installments or periodically during the 409A Deferral Period,  the payments which would otherwise have been made in the 409A Deferral Period shall be  accumulated and paid in a lump sum as soon as the 409A Deferral Period ends, and the  balance of the payments shall be made as otherwise scheduled. In the event benefits are  required to be deferred, any such benefit may be provided during the 409A Deferral Period  at Executive's expense, with Executive having a right to reimbursement from the Company  once the 409A Deferral Period ends, and the balance of the benefits shall be provided as  otherwise scheduled.       3. Knowing and Voluntary Acceptance of Agreement and Release    

 

     6   You acknowledge that you have carefully read the Agreement, understand its contents,  and have had the opportunity to consult with an attorney if you wish to do so. You acknowledge  that the Company advises you to consult with an attorney regarding this agreement. You  understand that you are releasing legal rights, including, without limitation, those identified in  the Release of Claims set forth above.  You also acknowledge that, as consideration for  executing this Agreement, including the Release of Claims, you are receiving additional benefits  and compensation to which you would not otherwise necessarily be entitled.      4. Applicable Law and Dispute Resolution    This Agreement shall be construed in accordance with and governed by the statutes and  common law of the state of North Carolina.  Any disputes arising in connection with the terms or  enforcement of this Agreement shall be resolved by confidential mediation or binding arbitration  in the State of North Carolina in accordance with the procedures of the American Arbitration  Association or other procedures agreed upon by you and the Company; provided, however, that  either party shall be entitled to seek provisional remedies in a court of competent jurisdiction.   The costs of mediation and arbitration shall be borne equally by you and the Company.    5. Confidential and Proprietary Information and Non-Competition; Continuing Duties    You acknowledge that you have a fiduciary duty as a former employee and officer of the  Company to keep confidential all proprietary and/or confidential information obtained by you  during the course of your employment (including, but not limited to, as set forth in your  Employment Agreement). You further acknowledge that you have continuing obligations to the  Company and its subsidiaries under the terms of your Employment Agreement, including but not  limited to non-compete and non-solicitation obligations. Additionally, you acknowledge that as a  former Section 16 officer of the Company, you have continuing obligations with respect to  reporting trades in the Company’s stock.  For a period of 6 months following your termination  date, you will continue to notify the Corporate Secretary both in advance and following any such  trades made by you or by any affiliated individual.     6. Intellectual Property   You acknowledge that all intellectual property (including without limitation any  invention, design, technique, patent, or the like) conceived or created by you during your  employment with the Company is the property of the Company. You also acknowledge that you  have an obligation to cooperate with the Company in disclosing such intellectual property to the  Company, and in assigning such intellectual property to the Company, including signing any  necessary documents.  You hereby acknowledge and expressly reaffirm these obligations, and  further agree to cooperate with the Company after your employment ends by disclosing and  confirming the Company's ownership in any such intellectual property conceived or created  during your employment with the Company (including without limitation signing necessary  documents at the Company's request), in exchange for the consideration provided to you under  this Agreement.   7. Indemnity  

 

     7      The Company acknowledges that it has previously agreed to certain indemnification  obligations as it relates to you (including, but not limited to, as set forth in your Employment  Agreement). The Company further acknowledges and reaffirms that those obligations continue  and survive your resignation. [In addition to the indemnification obligations previously agreed  to, the Company also agrees to provide you with reasonable compensation for your time  assisting, preparing, traveling, or testifying in any Proceeding (as defined in the Employment  Agreement), whether as a witness, party, or otherwise, in the amount of $[●] per hour.]      8. Company Property      You acknowledge that you must immediately return to the Company all Company-owned  equipment furnished to you, including but not limited to your company credit card, computer,  printer, fax machine, keys, etc. You may keep your company provided tablet (iPad) and cellular  phone (iPhone). This equipment must be returned in the same condition as it was when assigned  to you, excepting normal wear, and you must not alter, delete, or otherwise modify any  information contained on any such devices.  The Company’s obligations under this Agreement  are contingent upon your return of all such property, and no payments will be made to you until  such property has been returned.    9. Acknowledgement     You acknowledge that this Agreement contains the entire agreement and understanding  between you and the Company and supersedes and replaces all prior negotiations and agreements  concerning the subjects of this Agreement, except to the extent that your Employment  Agreement continues to apply.  You acknowledge that (a) you have read the Agreement and  understand the effect of your release and that you are releasing legal rights including without  limitation those identified in Paragraph 1; (b) are not relying on any representations or statements  made by the Company or its representatives, other than those specifically contained in this  Agreement; (c) you have had adequate time to consider this Agreement (as set forth below); (d)  as consideration for executing this Agreement, you have received additional benefits and  compensation of value to which you would not otherwise be entitled; and (e) you have been and  hereby are advised in writing to review this Agreement with legal counsel of your choice prior to  execution.    10. Time for Consideration of Offer and Agreement     You acknowledge that this offer provides you with a period of at least [●] days from the  date of receipt for your consideration of the offer (the “Consideration Period”). In the event you  have not executed this Agreement by the expiration of the Consideration Period, the offer shall  expire. You may execute this Agreement at any time during this Consideration Period.    This Agreement shall be effective on the date it is signed. However, you shall have a  period of [●] days from your execution of this Agreement in which you may revoke this  Agreement. Notice of this revocation, if any, shall be made in writing addressed to [NAME] in  the [OFFICE NAME] office with a copy to:      

 

     8  JELD-WEN Benefits and Administrative Services Department  Attn: [NAME]  [ADDRESS]    In the event you do not exercise your right to revoke this Agreement, this Agreement  shall remain in effect and shall become effective and irrevocable on the date immediately  following the [●] day revocation period described above.    11. Mutual Non-Disparagement    You agree that you will not make any untrue or misleading written or oral statement  about the Company and its current officers and directors, or about your employment at JELD- WEN, Inc., that is intended or would reasonably be expected to cause harm to its and/or their  reputation.  Similarly, the Company agrees that its current officers and directors (including  anyone acting expressly on their behalf) shall not make any untrue or misleading written or oral  statement about you or your employment at JELD-WEN, Inc. that is intended or would  reasonably be expected to cause harm to your reputation. You agree that you will not discuss  your employment, termination, or any other Company matters with any investors, analysts, or  other third parties; provided, however, that you and the Company will agree to appropriate  responses to be given by each party in response to inquiries from your future prospective  employers.     12. Severability    If any term, clause or portion of this Agreement shall, for any reason, be held to be  invalid or unenforceable or to be contrary to public policy or any law, then the remainder of this  Agreement shall not be affected by such invalidity or unenforceability but shall remain in full  force and effect, as if the invalid or unenforceable term or portion thereof had not existed within  this Agreement.    Sincerely,    JELD-WEN, Inc.           By: [NAME]   [TITLE]                   

 

     9   I have read and understand the foregoing Agreement and, by signing below, I knowingly  and voluntarily enter into this Agreement and understand that I am waiving and releasing legal  claims that I may have against the Company. I also understand that the Company may be  required to file this Agreement with the Securities and Exchange Commission pursuant to  applicable regulations.          Accepted:      , 2022                                            _________________________________                   __________________________________________  [NAME]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]